97 related articles for article (PubMed ID: 15845396)
21. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
[TBL] [Abstract][Full Text] [Related]
22. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP
Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630
[TBL] [Abstract][Full Text] [Related]
23. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
Dallinga-Thie GM; Dullaart RP; van Tol A
Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional determinants of human plasma phospholipid transfer protein activity as revealed by site-directed mutagenesis of charged amino acids.
Ponsin G; Qu SJ; Fan HZ; Pownall HJ
Biochemistry; 2003 Apr; 42(15):4444-51. PubMed ID: 12693940
[TBL] [Abstract][Full Text] [Related]
25. PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma.
Siggins S; Jauhiainen M; Olkkonen VM; Tenhunen J; Ehnholm C
J Lipid Res; 2003 Sep; 44(9):1698-704. PubMed ID: 12810820
[TBL] [Abstract][Full Text] [Related]
26. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
Attia N; Domingo N; Lorec AM; Nakbi A; Hammami S; Ben Hamda K; Portugal H; Lairon D; Hammami M; Chanussot F
Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989
[TBL] [Abstract][Full Text] [Related]
27. Plasma phospholipid transfer protein fused with green fluorescent protein is secreted by HepG2 cells and displays phosphatidylcholine transfer activity.
Siggins S; Ehnholm C; Jauhiainen M; Olkkonen VM
Biochem Cell Biol; 2006 Apr; 84(2):117-25. PubMed ID: 16609691
[TBL] [Abstract][Full Text] [Related]
28. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response.
Barlage S; Fröhlich D; Böttcher A; Jauhiainen M; Müller HP; Noetzel F; Rothe G; Schütt C; Linke RP; Lackner KJ; Ehnholm C; Schmitz G
J Lipid Res; 2001 Feb; 42(2):281-90. PubMed ID: 11181759
[TBL] [Abstract][Full Text] [Related]
29. Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins.
Saito H; Lund-Katz S; Phillips MC
Prog Lipid Res; 2004 Jul; 43(4):350-80. PubMed ID: 15234552
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I.
Yamato K; Tamasawa N; Murakami H; Matsui J; Tanabe J; Suda T; Yasujima M
Diabetes Res Clin Pract; 2005 Aug; 69(2):124-8. PubMed ID: 16005361
[TBL] [Abstract][Full Text] [Related]
31. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
[TBL] [Abstract][Full Text] [Related]
32. Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal fluid.
Salvatore A; Cigliano L; Carlucci A; Bucci EM; Abrescia P
J Neurochem; 2009 Jul; 110(1):255-63. PubMed ID: 19457062
[TBL] [Abstract][Full Text] [Related]
33. Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion.
Pandey NR; Renwick J; Misquith A; Sokoll K; Sparks DL
Biochemistry; 2008 Feb; 47(6):1579-87. PubMed ID: 18189424
[TBL] [Abstract][Full Text] [Related]
34. Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample.
Jänis MT; Siggins S; Tahvanainen E; Vikstedt R; Silander K; Metso J; Aromaa A; Taskinen MR; Olkkonen VM; Jauhiainen M; Ehnholm C
J Lipid Res; 2004 Dec; 45(12):2303-9. PubMed ID: 15342679
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes.
Dvorin E; Gorder NL; Benson DM; Gotto AM
J Biol Chem; 1986 Nov; 261(33):15714-8. PubMed ID: 3096996
[TBL] [Abstract][Full Text] [Related]
36. Stage-specific association of apolipoprotein A-I and E in developing mouse retina.
Kurumada S; Onishi A; Imai H; Ishii K; Kobayashi T; Sato SB
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1815-23. PubMed ID: 17389516
[TBL] [Abstract][Full Text] [Related]
37. Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA.
Siggins S; Kärkkäinen M; Tenhunen J; Metso J; Tahvanainen E; Olkkonen VM; Jauhiainen M; Ehnholm C
J Lipid Res; 2004 Feb; 45(2):387-95. PubMed ID: 14617737
[TBL] [Abstract][Full Text] [Related]
38. Preferential binding of apolipoprotein E derived peptides with oxidized phospholipid.
Pande AH; Tripathy RK
Biochem Biophys Res Commun; 2009 Feb; 380(1):71-5. PubMed ID: 19159618
[TBL] [Abstract][Full Text] [Related]
39. [A new property of known proteins: specific binding of thyroid hormones by human plasma apolipoproteins].
Sviridov OV
Biokhimiia; 1994 May; 59(5):625-38. PubMed ID: 8043689
[TBL] [Abstract][Full Text] [Related]
40. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
Vogt L; Laverman GD; van Tol A; Groen AK; Navis G; Dullaart RP
Nephrol Dial Transplant; 2006 Jan; 21(1):101-6. PubMed ID: 16141462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
